WO1980000007A1 - Medical sleeve - Google Patents
Medical sleeve Download PDFInfo
- Publication number
- WO1980000007A1 WO1980000007A1 PCT/US1979/000354 US7900354W WO8000007A1 WO 1980000007 A1 WO1980000007 A1 WO 1980000007A1 US 7900354 W US7900354 W US 7900354W WO 8000007 A1 WO8000007 A1 WO 8000007A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sleeve
- vessel
- set forth
- sheath
- medical device
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/003—Implantable devices or invasive measures inflatable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1002—Balloon catheters characterised by balloon shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/061—Blood vessels provided with means for allowing access to secondary lumens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1042—Alimentary tract
- A61M2210/1053—Stomach
Definitions
- a gastric bypass may be accomplished by anastomosing a minor portion of the stomach to the jejunum while leaving the major portion connected to the duodenum.
- an intestinal bypass involves the short-circuiting of a majority of the combined lengths of the jejunum and ileu by connecting the first part of the jejunum to the last part of the ileum.
- O PI Beyond statistically significant operative and overall mortality rates, reported complications following the gastri bypass include marginal ulcers and wound infections.
- the intestinal bypass involves similar mortality rates and, reportedly, a greater number of postoperative complications and side effects. These include pulmonary emboli, wound infections, gastrointestinal hemorrhage, renal failure, and numerous other disorders. The nature, severity, and fre ⁇ quency of these problems have in fact led to doubts as to th advisability of the techniques for treatment of obesity.
- the invention provides a method and means for iso ⁇ lating the internal walls of hollow viscera or other body vessels from contact with materials, both fluids and solids, occurring naturally, ingested, or otherwise introduced into body vessel.
- Isolation of a body vessel is achieved by positioning and anchoring a sleeve, impervious to materials sought to be isolated within the ves sel, in such a manner that the sleeve, at least adjacent its upstream end, is in sealing engagement with the surrounding interior tissue of the vessel. Material otherwise normally flowing into the vessel and being capable of interracting with the vessel to the detriment of the patient's health is thereby contained and rendered ineffectual on or unaffected by the vessel.
- a sleeve impervious to both gastr ⁇ secretions and food substances is disposed within the stomach in a manner which prevents contact between these gastric se ⁇ cretions and food substances. More specifically, the sleeve acts as a liner for at least a portion of the internal stom ⁇ ach area while also providing a conduit for food passing through the stomach.
- the sleeve which is capable of estab ⁇ lishing a circumferential, substantially fluid-tight seal with the walls of the stomach adjacent its upstream end, may be any desired length so that a suitable portion of the in ⁇ ternal stomach area is rendered ineffectual in the digestive process. Consequently, the sleeve is operative to limit the efficienc of food absorption in the small intestine.
- the sleeve may be introduced into the stomach through the oral cavity and esophagus.
- the sleeve is sufficiently flexible to be collapsed into a unit of relatively low bulk for ease of passage through the posterior pharynx and esophagus.
- the sleeve is expanded by means carried with the sleeve, including a flexi ⁇ ble tube trailing the sleeve.
- a source of pressurized fluid external of the patient's body is operably connected to the expanding means through this trailing tube to expand the sleeve into sealing engagement with the walls of the stom ⁇ ach.
- the sleeve may be additionally restrained against further movement along the digestive tract by anchoring the trailing tube or a separate parallel element upstream in the digestive tract.
- the tissue isolating function of the disclosed sleeve in addition to control of the mechanism of digestion, has numerous other applications in diagnosis or treatment of body disorders.
- the sleeve may be used to chem ⁇ ically and/or physically protect tissue which has been ulcer ⁇ ated, herniated, fissured, or the like from natural body fluids. Ruptured blood vessels or aneurysms may be protected from further damage and allowed to heal by isolating the ef ⁇ fect of normal blood pressure from the vessel by containing it within the sleeve.
- Stenosis or a sclerotic closing of an artery may be expanded from within by the use of internal compression while still allowing blood to pass through, especially in those individuals whose disease is so far advanced that a graft could not be sutured to the distal portion of *the vessel.
- one or more tubes connected to the sleeve may be arranged to provide communication between the annular zone intermediate the protected vessel and the outer surface of the sleeve for introduction of medicines or aspiration of fluids from the zone.
- FIG. 1 is a perspective view of a vessel-insertable medical sleeve unit constructed in accordance with the inven ⁇ tion;
- FIG. 2 is a fragmentary, cross sectional view on an enlarged scale through the wall of the sleeve unit, taken along the line 2-2 of FIG. 1;
- FIG. 2a is a fragmentary, cross sectional view simi ⁇ lar to FIG. 3, taken along the line 2 -2_ of FIG. 1;
- FIG. 3 is a fragmentary, cross sectional view on an enlarged scale, taken along the line 3-3 of FIG. 1 of a trailing filament of the sleeve unit;
- FIG. 4 is a schematic illustration of a manner of use of the sleeve to control obesity;
- FIG. 5 is a view of the sleeve unit in a compacted condition and contained within a dialator shell for instal ⁇ lation;
- FIG. 6 is a view of the sleeve unit depicting an intermediate configuration in a progressive sequence of expansion from the condition of FIG. 4;
- FIG. 7 is a view of the sleeve progressed in its transition from FIG. 5 through FIG. 6 to a fully expanded configuration essentially corresponding, to FIG. 4;
- FIG. 8 is a schematic view of a second embodiment of the sleeve of the invention employed within an aorta.
- a sleeve unit 10 in the form of a cylindrical, tubular sheath 11 and one or more inflator ring balloons 12-14.
- the sheath 11 in the illustrated example is a flexible membrane of nontoxic material impervious and chem ⁇ ically resistant to body fluids which it is expected to en ⁇ counter.
- the sheath material is selected from a variety of known plastic and/or elastomeric substances.
- the sheath 11 may be extruded, rolled, or otherwise formed, as desired, into a tube with or without a longitudinal seam or seams.
- the inflator ring balloons 12-14 as indicated in FIG. 1 are flexible, hollow, torroid-like elements spaced axially along the interior of the sheath 11. As indicated, the rings 12 and 14 are adjacent opposite ends 16 and 17 of the sheath 11.
- the ring balloons 12-14 may be formed of a material the same as or like that of the sheath 11, and are either integrally formed thereon or are bonded thereto by heat, adhesive, solvent or like means. While the sheath 11 is illustrated as a cylinder, it will be understood that it may take other configurations, such as a frustum or a sphere truncated adjacent opposite poles, or a tubular elbow of con stant or varying diameter.
- the sleeve unit 10 includes at least one, and preferably two, trailing hollow filaments 20,21 connected thereto by bonding or other suitable means. These filaments 20,21 may be made of the same or similar material as the sheath 11.
- each of the filaments 20-21 includes a central lumen 22 and an auxil obviouslyy lumen 23. When desired or necessary, additional lumens may be disposed in the wall of each filament 20-21.
- one of the filaments 20 has its central lumen 22 in fluid communication with an upstream one 12 of the ring balloons, while the other filament 21 has its central lumen 22 in flui communication with the remaining ring balloons 13 and 14.
- longitudinally spaced, gen ⁇ erally radial passages 26 provide communication from the auxiliary lumens 23 of each filament 20, 21 through the adjacent wall of the sheath 11 to points external of the sleeve unit 10.
- the exterior surface of the filaments 20,21 and internal surface of the sheath 11 are sealed to one another by suitable means, such as bonding or the like, at their points of tangency so that fluids in the auxiliary lumens cannot escape into the interior, designated 27, of th sheath 11 at the radial passages or apertures 26.
- the sleeve unit 10 is implanted in a body vessel in order to isolate the walls of such vessel from fluids normal ⁇ ly flowing into it.
- FIG. 4 illustrates a manner of use of the sleeve unit 10 to isolate the internal surface area or lumen, designated 31, of a human stomach 32 and its secre ⁇ tions from food substances passing through it.
- the sleeve unit 10 is implanted in the stomach 32 in a nonsurgical man ⁇ ner by passing it through an oral cavity 33, pharynx 34, and esophagus 35.
- the sleeve unit is folded on itself accordion fashion to reduce its length and diameter. In its folded or compacted state, the sleeve unit 10 is contained within a dialator shell or cup 37 (Figs. 5 and 6) .
- the dialator shell 37 has .a rounded profile for ease of passage through the natural lumen of the digestive tract, generally indicated at 39 (FIG. 4).
- the dialator shell 37 carrying the collapsed sleeve unit 10 is inserted through the epiglotis, whereupon natural- swallowing action allows it to be readily " advanced into the stomach 32.
- FIG. 6 depicts this action, wherein the dialator shell 37 is released from the sleeve unit 10 and allowed to pass through the lower portion of the digestive tract 39.
- the sleeve unit 10 in a continuous sequence of movement expands from the intermediate position of FIG. 6 to that of FIG. 7.
- the final position of the sleeve unit 10 in the stomach 32 may be adjusted by pumping fluid through the auxiliary lumens 23 in such a manner that it issues passages 26 as a jet developing a reaction force to shift the adjacent area of the sleeve unit in one direction or another, depending on the orientation of the passages.
- These passages 26 may be provided with either an axial or tangential compo ⁇ nent in their orientation with respect to the axial direction of the sleeve to cause corresponding axial or turning move ⁇ ment of the sleeve.
- the sleeve unit 10 includ ⁇ ing the filaments 20, 21 and ring balloons 12-14, is provided with sufficient radiopaque material to permit external obser ⁇ vation of its position and configuration.
- the ring balloons 12-14 are finally inflated through the central filament lumens 22, again by a source of pressurized fluid external of the patient's body. Inflation of the ring balloons 12-14 causes them, in the manner of circumferential stiffening ribs, to fully expand the sleeve into tight sealing engage ⁇ ment with the interior surface 31 of the stomach vessel 32.
- the ends of the filaments 20, " 21 ⁇ distal from the ⁇ sle ⁇ eve ⁇ unit 10 are anchored to a posterior tooth or prosthesis by suit ⁇ able fastening means or are sutured in place.
- the central or main lumens 22 of the filaments 20,21 are closed at these anchoring points by heat sealing, plugging, or the like, to indefinitely maintain a pressurized state in the connected ring balloons 12-14 to keep the adjacent sleeve areas in fluid-tight engagement with the stomach wall 31.
- the middle and lower ring balloons 13, 14 may be intermittently or permanently depressurized so that these fluids may pass through the remainder of the digestive tract.
- fluids secreted by the stomach area 31 shielded by the sleeve unit 10 may be aspirated through the oral cavity by way of the auxiliary lumens 23 and passages 26.
- medicine may be carried into the annular zone defined between the sheath 11 and stomach waTTp 31 through the oral cavity by way of the auxiliary lumens 23 and passages 26.
- the sleeve unit 10 by isolating the walls 31 of the stomach 32 from ingested food passing through it, reduces the digestive efficiency of the stomach. This results from interference with the normal contact of gastric juices, secreted by the stomach walls 31, on such food and the inability of the intestines of the lower digestive tract to absorb undigested food.
- the patient while consuming food in even large quantities, is enabled to lose weight, since only a limited amount of the ingested food is ultimate ⁇ ly absorbed.
- the sleeve 10 may be disposed in the small intestine, rather than in the stomach, to directly reduce the effective area of the intestine available for absorption, again for the control of obesity.
- the sleeve may be utilized to medicate an ulcerous zone and isolate it from gastric juices to hasten normal recovery.
- FIG. 8 there is shown a second embodiment of the invention wherein a sleeve 25 is disposed within a human aorta 30 and associated right and left common iliac arteries 31, 32.
- the sleeve 25 is bifurcated at one end to provide a pair of branches 25a and 25b corresponding to the right and left common iliac arteries 31, 32 respec ⁇ tively.
- the sleeve 25 has a construction essentially the same as the earlier-described sleeve 10.
- Ring balloons 33 are spaced axially along the sleeve including the branch portions 25a,25b. Each of the ring balloons 33 is in fluid communication with at least one hollow filament 34,35 for purposes of inflation.
- the sleeve 25 is advantageously employed in cases o advanced blood vessel disease where a patient's tissue is such that it is impossible to sew or anastomose it with grafts or artificial vessels.
- An incision 41 is made in the vessel 30 to allow the positioning of the sleeve 25 therein.
- the sleeve 25 is expanded into position by directing fluid pressure into the elongated filaments 34,35 in any suitable manner such as disclosed above with use of free extensions (not shown) of these filaments.
- the sleeve 25 is anchored in the vessel 30, for example, by sutures 42 near the incision 41, while the dista portion of the sleeve remains free.
- One or more holes 43 may be cut into the wall of the sleeve prior to placement within the vessel to provide blood flow to various arterial branches 46.
- the sleeve 25 is preferably formed of relatively inelas ⁇ tic material or otherwise is circumferentially reinforced with inelastic material along its length so that the pressure of blood flowing through the_ sleeve is_ effectively isolated from the vessel 30.
Abstract
A method and article for medical diagnosis and/or treatment of body disorders, comprising a sleeve unit (10) insertable in a natural body vessel to isolate material flowing into the vessel from direct contact with the interior surface of the vessel. When applied to the treatment of obesity, the sleeve is disposed along a zone in the digestive tract (32) to interfere with the digestive or absorptive function of that zone and thereby reduce net caloric intake.
Description
MEDICAL SLEEVE
■BACKGROUND OF THE INVENTION
In the diagnosis and/or treatment of disorders of the body, it is known to physically alter the condition or function of hollow viscera or other internal body vessels. Surgical procedures on such vessels include reconstruction of natural tissue, substitution and bypass techniques with natural or artificial implants. Surgery is recognized as always carrying some degree of risk to the patient, both dur¬ ing its actual performance and in postoperative complications or side effects. These risks, of course, are of major con¬ cern when the surgery involves the invasion of the great cavity of the trunk of the human body. This is especially true in treatment of such viscera as the heart, liver, or intestines, and in particular when such surgery involves these organs themselves.
In surgical treatment of obesity, for example, the abdominal cavity is exposed to allow reconstruction of the digestive tract, in essence, to reduce the internal surface area available for food digestion or absorption of digested substances. The former technique, a gastric bypass, may be accomplished by anastomosing a minor portion of the stomach to the jejunum while leaving the major portion connected to the duodenum. The latter of these techniques, an intestinal bypass, involves the short-circuiting of a majority of the combined lengths of the jejunum and ileu by connecting the first part of the jejunum to the last part of the ileum.
Both of these operations are deemed to involve such high risk to the patient that they are considered only as a lifesaving undertaking for morbidly obese individuals.
O PI
Beyond statistically significant operative and overall mortality rates, reported complications following the gastri bypass include marginal ulcers and wound infections. The intestinal bypass involves similar mortality rates and, reportedly, a greater number of postoperative complications and side effects. These include pulmonary emboli, wound infections, gastrointestinal hemorrhage, renal failure, and numerous other disorders. The nature, severity, and fre¬ quency of these problems have in fact led to doubts as to th advisability of the techniques for treatment of obesity.
SUMMARY OF THE INVENTION
The invention provides a method and means for iso¬ lating the internal walls of hollow viscera or other body vessels from contact with materials, both fluids and solids, occurring naturally, ingested, or otherwise introduced into body vessel. Isolation of a body vessel, according to the invention, is achieved by positioning and anchoring a sleeve, impervious to materials sought to be isolated within the ves sel, in such a manner that the sleeve, at least adjacent its upstream end, is in sealing engagement with the surrounding interior tissue of the vessel. Material otherwise normally flowing into the vessel and being capable of interracting with the vessel to the detriment of the patient's health is thereby contained and rendered ineffectual on or unaffected by the vessel.
An important application of the invention is the nonsurgical treatment of obesity through reduction in the effective natural surface area of the digestive tract. In one disclosed embodiment, a sleeve impervious to both gastr^
secretions and food substances is disposed within the stomach in a manner which prevents contact between these gastric se¬ cretions and food substances. More specifically, the sleeve acts as a liner for at least a portion of the internal stom¬ ach area while also providing a conduit for food passing through the stomach. The sleeve, which is capable of estab¬ lishing a circumferential, substantially fluid-tight seal with the walls of the stomach adjacent its upstream end, may be any desired length so that a suitable portion of the in¬ ternal stomach area is rendered ineffectual in the digestive process. Consequently, the sleeve is operative to limit the efficienc of food absorption in the small intestine.
As disclosed, the sleeve may be introduced into the stomach through the oral cavity and esophagus. In the pre¬ ferred embodiment, the sleeve is sufficiently flexible to be collapsed into a unit of relatively low bulk for ease of passage through the posterior pharynx and esophagus. Upon reaching a desired position in the stomach, the sleeve is expanded by means carried with the sleeve, including a flexi¬ ble tube trailing the sleeve. A source of pressurized fluid external of the patient's body is operably connected to the expanding means through this trailing tube to expand the sleeve into sealing engagement with the walls of the stom¬ ach. The sleeve may be additionally restrained against further movement along the digestive tract by anchoring the trailing tube or a separate parallel element upstream in the digestive tract.
The tissue isolating function of the disclosed sleeve, in addition to control of the mechanism of digestion, has numerous other applications in diagnosis or treatment of body disorders. For example, the sleeve may be used to chem¬ ically and/or physically protect tissue which has been ulcer¬ ated, herniated, fissured, or the like from natural body fluids. Ruptured blood vessels or aneurysms may be protected
from further damage and allowed to heal by isolating the ef¬ fect of normal blood pressure from the vessel by containing it within the sleeve.
Stenosis or a sclerotic closing of an artery may be expanded from within by the use of internal compression while still allowing blood to pass through, especially in those individuals whose disease is so far advanced that a graft could not be sutured to the distal portion of *the vessel. Still further, where desired, one or more tubes connected to the sleeve may be arranged to provide communication between the annular zone intermediate the protected vessel and the outer surface of the sleeve for introduction of medicines or aspiration of fluids from the zone.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a perspective view of a vessel-insertable medical sleeve unit constructed in accordance with the inven¬ tion;
FIG. 2 is a fragmentary, cross sectional view on an enlarged scale through the wall of the sleeve unit, taken along the line 2-2 of FIG. 1;
FIG. 2a is a fragmentary, cross sectional view simi¬ lar to FIG. 3, taken along the line 2 -2_ of FIG. 1;
FIG. 3 is a fragmentary, cross sectional view on an enlarged scale, taken along the line 3-3 of FIG. 1 of a trailing filament of the sleeve unit;
FIG. 4 is a schematic illustration of a manner of use of the sleeve to control obesity;
FIG. 5 is a view of the sleeve unit in a compacted condition and contained within a dialator shell for instal¬ lation;
FIG. 6 is a view of the sleeve unit depicting an intermediate configuration in a progressive sequence of expansion from the condition of FIG. 4;
FIG. 7 is a view of the sleeve progressed in its transition from FIG. 5 through FIG. 6 to a fully expanded configuration essentially corresponding, to FIG. 4; and
FIG. 8 is a schematic view of a second embodiment of the sleeve of the invention employed within an aorta.
DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring now to the drawings, and in particular to FIG. 1, there is shown a sleeve unit 10 in the form of a cylindrical, tubular sheath 11 and one or more inflator ring balloons 12-14. The sheath 11 in the illustrated example is a flexible membrane of nontoxic material impervious and chem¬ ically resistant to body fluids which it is expected to en¬ counter. The sheath material is selected from a variety of known plastic and/or elastomeric substances. The sheath 11 may be extruded, rolled, or otherwise formed, as desired, into a tube with or without a longitudinal seam or seams.
O PI 1P0 -
The inflator ring balloons 12-14 as indicated in FIG. 1 are flexible, hollow, torroid-like elements spaced axially along the interior of the sheath 11. As indicated, the rings 12 and 14 are adjacent opposite ends 16 and 17 of the sheath 11. The ring balloons 12-14 may be formed of a material the same as or like that of the sheath 11, and are either integrally formed thereon or are bonded thereto by heat, adhesive, solvent or like means. While the sheath 11 is illustrated as a cylinder, it will be understood that it may take other configurations, such as a frustum or a sphere truncated adjacent opposite poles, or a tubular elbow of con stant or varying diameter. The sleeve unit 10 includes at least one, and preferably two, trailing hollow filaments 20,21 connected thereto by bonding or other suitable means. These filaments 20,21 may be made of the same or similar material as the sheath 11. In the illustrated case, each of the filaments 20-21 includes a central lumen 22 and an auxil iary lumen 23. When desired or necessary, additional lumens may be disposed in the wall of each filament 20-21. Ideally one of the filaments 20 has its central lumen 22 in fluid communication with an upstream one 12 of the ring balloons, while the other filament 21 has its central lumen 22 in flui communication with the remaining ring balloons 13 and 14.
As suggested in FIG. 3, longitudinally spaced, gen¬ erally radial passages 26 provide communication from the auxiliary lumens 23 of each filament 20, 21 through the adjacent wall of the sheath 11 to points external of the sleeve unit 10. The exterior surface of the filaments 20,21 and internal surface of the sheath 11 are sealed to one another by suitable means, such as bonding or the like, at their points of tangency so that fluids in the auxiliary lumens cannot escape into the interior, designated 27, of th sheath 11 at the radial passages or apertures 26.
The sleeve unit 10 is implanted in a body vessel in order to isolate the walls of such vessel from fluids normal¬ ly flowing into it. FIG. 4 illustrates a manner of use of the sleeve unit 10 to isolate the internal surface area or lumen, designated 31, of a human stomach 32 and its secre¬ tions from food substances passing through it. The sleeve unit 10 is implanted in the stomach 32 in a nonsurgical man¬ ner by passing it through an oral cavity 33, pharynx 34, and esophagus 35. To facilitate introduction of the sleeve unit 10 into the stomach 32, the sleeve unit is folded on itself accordion fashion to reduce its length and diameter. In its folded or compacted state, the sleeve unit 10 is contained within a dialator shell or cup 37 (Figs. 5 and 6) . The dialator shell 37 has .a rounded profile for ease of passage through the natural lumen of the digestive tract, generally indicated at 39 (FIG. 4). The dialator shell 37 carrying the collapsed sleeve unit 10 is inserted through the epiglotis, whereupon natural- swallowing action allows it to be readily" advanced into the stomach 32.
Upon reaching the stomach 32, one or both of the central lumens 22 of the filaments 20,21 are connected to a source of pressurized fluid, such as air, ordinarily external of the oral cavity 33. Lower sections of the filaments 20, 21 longitu inally associated with the sheath 11 develop forces upon pressurization, tending to unfold themselves along with the sheath. FIG. 6 depicts this action, wherein the dialator shell 37 is released from the sleeve unit 10 and allowed to pass through the lower portion of the digestive tract 39. The sleeve unit 10 in a continuous sequence of movement expands from the intermediate position of FIG. 6 to that of FIG. 7.
The final position of the sleeve unit 10 in the stomach 32 may be adjusted by pumping fluid through the auxiliary lumens 23 in such a manner that it issues
passages 26 as a jet developing a reaction force to shift the adjacent area of the sleeve unit in one direction or another, depending on the orientation of the passages. These passages 26 may be provided with either an axial or tangential compo¬ nent in their orientation with respect to the axial direction of the sleeve to cause corresponding axial or turning move¬ ment of the sleeve. Preferably, the sleeve unit 10, includ¬ ing the filaments 20, 21 and ring balloons 12-14, is provided with sufficient radiopaque material to permit external obser¬ vation of its position and configuration. When the position of the sleeve unit 10 is satisfactory, the ring balloons 12-14 are finally inflated through the central filament lumens 22, again by a source of pressurized fluid external of the patient's body. Inflation of the ring balloons 12-14 causes them, in the manner of circumferential stiffening ribs, to fully expand the sleeve into tight sealing engage¬ ment with the interior surface 31 of the stomach vessel 32. The ends of the filaments 20,"21~distal from the ~sle~eve~ unit 10 are anchored to a posterior tooth or prosthesis by suit¬ able fastening means or are sutured in place. The central or main lumens 22 of the filaments 20,21 are closed at these anchoring points by heat sealing, plugging, or the like, to indefinitely maintain a pressurized state in the connected ring balloons 12-14 to keep the adjacent sleeve areas in fluid-tight engagement with the stomach wall 31. Where desired, for example, to release fluids secreted by the stomach walls 31, the middle and lower ring balloons 13, 14 may be intermittently or permanently depressurized so that these fluids may pass through the remainder of the digestive tract. Alternatively, fluids secreted by the stomach area 31 shielded by the sleeve unit 10 may be aspirated through the oral cavity by way of the auxiliary lumens 23 and passages 26. Moreover, if desired, medicine may be carried into the annular zone defined between the sheath 11 and stomach waTTp
31 through the oral cavity by way of the auxiliary lumens 23 and passages 26.
The sleeve unit 10, by isolating the walls 31 of the stomach 32 from ingested food passing through it, reduces the digestive efficiency of the stomach. This results from interference with the normal contact of gastric juices, secreted by the stomach walls 31, on such food and the inability of the intestines of the lower digestive tract to absorb undigested food. Thus, the patient, while consuming food in even large quantities, is enabled to lose weight, since only a limited amount of the ingested food is ultimate¬ ly absorbed.
Various other uses of the disclosed sleeve 10 or its equivalents are contemplated in the treatment of body disor¬ ders. For instance, the sleeve 10 may be disposed in the small intestine, rather than in the stomach, to directly reduce the effective area of the intestine available for absorption, again for the control of obesity. When disposed in the stomach, the sleeve may be utilized to medicate an ulcerous zone and isolate it from gastric juices to hasten normal recovery.
Referring now to FIG. 8, there is shown a second embodiment of the invention wherein a sleeve 25 is disposed within a human aorta 30 and associated right and left common iliac arteries 31, 32. The sleeve 25 is bifurcated at one end to provide a pair of branches 25a and 25b corresponding to the right and left common iliac arteries 31, 32 respec¬ tively. The sleeve 25 has a construction essentially the same as the earlier-described sleeve 10. Ring balloons 33 are spaced axially along the sleeve including the branch portions 25a,25b. Each of the ring balloons 33 is in fluid communication with at least one hollow filament 34,35 for purposes of inflation.
The sleeve 25 is advantageously employed in cases o advanced blood vessel disease where a patient's tissue is such that it is impossible to sew or anastomose it with grafts or artificial vessels. An incision 41 is made in the vessel 30 to allow the positioning of the sleeve 25 therein. The sleeve 25 is expanded into position by directing fluid pressure into the elongated filaments 34,35 in any suitable manner such as disclosed above with use of free extensions (not shown) of these filaments.
The sleeve 25 is anchored in the vessel 30, for example, by sutures 42 near the incision 41, while the dista portion of the sleeve remains free. One or more holes 43 ma be cut into the wall of the sleeve prior to placement within the vessel to provide blood flow to various arterial branches 46. The sleeve 25 is preferably formed of relatively inelas¬ tic material or otherwise is circumferentially reinforced with inelastic material along its length so that the pressure of blood flowing through the_ sleeve is_ effectively isolated from the vessel 30.
The invention is not restricted to the slavish imi¬ tation of each and every detail set forth above. Obviously, devices may be provided which change, eliminate, or add cer¬ tain specific details without departing from the scope of the invention.
Claims
1. A medical device for treatment of body disor¬ ders, comprising a tubular sleeve adapted to isolate the inner walls of a hollow body vessel from material flowing into the vessel, said sleeve being formed of a material which is impervious, nontoxic, and resistant to attack by antici¬ pated body chemicals and medicines, said sleeve being suffi¬ ciently flexible to be folded on itself to thereby reduce its bulk from a normal configuration to a compacted configuration to facilitate initial placement of the sleeve into the body vessel.
2. A medical device as set forth in claim 1, wherein said sleeve includes means for remotely controlling transition of said sleeve from said compacted configuration to said normal configuration.
3. A medical device for the treatment of body dis¬ orders comprising a tubular sleeve adapted to isolate the inner walls of a hollow body vessel from material flowing into the vessel, said sleeve being formed of a material which is impervious, nontoxic, and resistant to attack by antici¬ pated body chemicals and medicines, said sleeve being formed of a relatively flexible sheath having at least one circum¬ ferential stiffening rib thereon, said circumferential stiff¬ ening rib being adapted to hold said sleeve in fluid-tight engagement with the interior walls of the body vessel.
4. A medical device as set forth in claim 3, where¬ in said circumferential stiffening tube is inflatable to control its stiffness.
5. A medical device as set forth in claim 4, where¬ in said rib is a hollow, torroidal ring, at least one trail¬ ing tube having a lumen in communication with the hollow interior of said rib to permit remote inflation of said rib.
6. A medical device as set forth in claim 5, including means for anchoring said sleeve in said vessel at a point in a body remote from said sleeve.
7. A medical device for treatment of body disorders comprising a tubular sleeve adapted to isolate the interior walls of a hollow body vessel from material flowing into the vessel, said sleeve being formed of material which is imper¬ vious, nontoxic, and resistant to attack by anticipated body chemicals and medicines, said sleeve being sufficiently flexible to be folded on itself to reduce its bulk for implantation in said vessel through a natural body lumen leading to the site of said interior vessel walls, at least one ring balloon extending circumferentially on said sheath, said ring balloon having the configuration of a hollow torroid and being inflatable to radially extend said sheath, elongated hollow filament means connected to said sheath, a lumen in said filament means being in communication with the interior of said ring balloon to permit said ring balloon to be pressurized from a point remote from said sleeve.
8. A medical device as set forth in claim 7, where¬ in said sleeve includes a hollow filament portion extending axially along the sleeve, said filament portion being adapted to be remotely pressurized and, upon pressurization, being arranged to axially extend said sleeve.
9. A medical device as set forth in claim 7, where¬ in said sleeve includes a ring balloon adjacent each end thereof, said ring balloons being inflatable through said hollow filament means to seal each end of said sleeve to the interior walls of said body vessel to thereby define an annu¬ lar zone between said sleeve and the interior walls of said body vessel.
10. A medical device as set forth in claim 7, wherein said sleeve is provided with generally radial passage means therethrough, and means including an elongated lumen connected to said passage means to provide communication between an annular zone between said sleeve and said body vessel and a point remote from said sleeve.
11. A medical device as set forth in claim 10, wherein said passage means is arranged to form a reaction jet when fluid is pumped through said elongated lumen to position said sleeve in said body vessel.
12. A medical device as set forth in claim 7, including a dialator shell having a cavity for receiving the sleeve when it is in a folded condition and having a rounded forward end portion for facilitating movement thereof throug said body vessel.
13. A medical device as set forth in claim 12, wherein said shell is arranged to be ejected from said sleev when said filament means is pressurized and said sleeve is expanded by said ring balloon.
14. _A method of isolating a hallow body vessel fro fluid passing into it, comprising the steps of passing an impervious sheath axially into the vessel through its natura lumen, aligning an end opening of the sheath axially with an upstream end of the zone of the- vessel sought to be isolated and expanding said open end radially into circumferential sealing engagement with the interior walls of the body vesse
15. A method as set forth in claim 14, wherein sai sheath is expanded into sealing engagement with the interior walls of said vessel by means remote from said zone, said remote expanding means being in communication with said sheath through a natural body lumen connected with said vessel.
OM W1
16. A method as set forth in claim 15, wherein said sleeve is provided with inflatable means operative upon inflation to expand said sheath into sealing engagement with the walls of said vessel, and inflating said inflatable means through an artificial lumen extending through said natural body lumen to said remote means.
17. A method as set forth in claim 16, wherein said inflatable means is arranged circumferentially about said sheath such that inflation thereof causes radial extension of said sheath.
18. A method as set forth in claim 17, wherein said inflatable means is arranged axially of said sheath such that inflation thereof causes axial extension of said sheath.
19. A method of controlling obesity, comprising the steps of positioning a sleeve impervious to digestive juices and normal foods in the digestive tract, arranging the sleeve in the digestive tract in such a manner that food material passing through the digestive tract is caused to pass through the sleeve while being isolated from direct contact with the surrounding area of the interior walls of the digestive tract and body fluids secreted by such surrounding area interior walls such that natural absorption of food material in the digestive tract is impaired and a net caloric intake for a given quantity of ingested food is thereby reduced.
20. A method as set forth in claim 19, wherein sa sleeve is disposed in the stomach.
21. A method as set forth in claim 19, wherein sa sleeve is anchored in position in said digestive tract by means extending through the digestive tract to the oral cavity.
22. A method as set forth in claim 19, wherein sa sleeve is positioned in said digestive tract through the or cavity.
23. A method as set forth in claim 22, wherein sa sleeve is passed through the oral cavity and other upper areas of the digestive tract in a compacted condition and i expanded into sealing contact with at least a portion of sa surrounding area of said interior walls.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91201078A | 1978-06-02 | 1978-06-02 | |
US912010 | 1978-06-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1980000007A1 true WO1980000007A1 (en) | 1980-01-10 |
Family
ID=25431251
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1979/000354 WO1980000007A1 (en) | 1978-06-02 | 1979-05-25 | Medical sleeve |
Country Status (4)
Country | Link |
---|---|
US (2) | US4501264A (en) |
EP (1) | EP0016047A1 (en) |
IL (1) | IL57559A (en) |
WO (1) | WO1980000007A1 (en) |
Cited By (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2497673A1 (en) * | 1981-01-14 | 1982-07-16 | Harboe Henrik | DEVICE FOR REDUCING THE AVAILABLE VOLUME OF HUMAN STOMACH |
US4416267A (en) * | 1981-12-10 | 1983-11-22 | Garren Lloyd R | Method and apparatus for treating obesity |
US4485805A (en) * | 1982-08-24 | 1984-12-04 | Gunther Pacific Limited Of Hong Kong | Weight loss device and method |
EP0137878A1 (en) * | 1983-09-06 | 1985-04-24 | Lloyd R. Garren | Stomach insert for treating obesity |
US5401241A (en) * | 1992-05-07 | 1995-03-28 | Inamed Development Co. | Duodenal intubation catheter |
WO2004041133A1 (en) * | 2002-11-01 | 2004-05-21 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
FR2853829A1 (en) * | 2003-04-16 | 2004-10-22 | Cie Euro Etude Rech Paroscopie | Intra-gastric implant insertion assembly includes sheath with opening edge fastened by releasable locking strip |
US7037344B2 (en) | 2002-11-01 | 2006-05-02 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
EP2164558A1 (en) * | 2007-06-08 | 2010-03-24 | Valentx, Inc. | Methods and devices for intragastric support of functional or prosthetic gastrointestinal devices |
US7892214B2 (en) | 2002-11-01 | 2011-02-22 | Valentx, Inc. | Attachment system for transmural attachment at the gastroesophageal junction |
US8956318B2 (en) | 2012-05-31 | 2015-02-17 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9060844B2 (en) | 2002-11-01 | 2015-06-23 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US9451960B2 (en) | 2012-05-31 | 2016-09-27 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9675489B2 (en) | 2012-05-31 | 2017-06-13 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9757264B2 (en) | 2013-03-13 | 2017-09-12 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
Families Citing this family (283)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4905693A (en) * | 1983-10-03 | 1990-03-06 | Biagio Ravo | Surgical method for using an intraintestinal bypass graft |
US4719916A (en) * | 1983-10-03 | 1988-01-19 | Biagio Ravo | Intraintestinal bypass tube |
US5104399A (en) | 1986-12-10 | 1992-04-14 | Endovascular Technologies, Inc. | Artificial graft and implantation method |
US4592339A (en) * | 1985-06-12 | 1986-06-03 | Mentor Corporation | Gastric banding device |
JPS62236560A (en) * | 1986-04-09 | 1987-10-16 | テルモ株式会社 | Catheter for repairing blood vessel |
US4793348A (en) * | 1986-11-15 | 1988-12-27 | Palmaz Julio C | Balloon expandable vena cava filter to prevent migration of lower extremity venous clots into the pulmonary circulation |
US4762128A (en) * | 1986-12-09 | 1988-08-09 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US5527336A (en) * | 1986-12-09 | 1996-06-18 | Boston Scientific Corporation | Flow obstruction treatment method |
US4893623A (en) * | 1986-12-09 | 1990-01-16 | Advanced Surgical Intervention, Inc. | Method and apparatus for treating hypertrophy of the prostate gland |
US5041126A (en) * | 1987-03-13 | 1991-08-20 | Cook Incorporated | Endovascular stent and delivery system |
US4800882A (en) * | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US20040127969A1 (en) * | 1987-04-06 | 2004-07-01 | Lazarus Harrison M. | Artificial graft and implantation method |
US5133732A (en) | 1987-10-19 | 1992-07-28 | Medtronic, Inc. | Intravascular stent |
US4909252A (en) * | 1988-05-26 | 1990-03-20 | The Regents Of The Univ. Of California | Perfusion balloon catheter |
US4925446A (en) * | 1988-07-06 | 1990-05-15 | Transpharm Group Inc. | Removable inflatable intragastrointestinal device for delivering beneficial agents |
US5007790A (en) * | 1989-04-11 | 1991-04-16 | Depomed Systems, Inc. | Sustained-release oral drug dosage form |
US6004261A (en) * | 1989-04-28 | 1999-12-21 | C. R. Bard, Inc. | Formed-in-place endovascular stent and delivery system |
US5100429A (en) * | 1989-04-28 | 1992-03-31 | C. R. Bard, Inc. | Endovascular stent and delivery system |
US4994071A (en) * | 1989-05-22 | 1991-02-19 | Cordis Corporation | Bifurcating stent apparatus and method |
US4994033A (en) * | 1989-05-25 | 1991-02-19 | Schneider (Usa) Inc. | Intravascular drug delivery dilatation catheter |
US5049131A (en) * | 1989-05-31 | 1991-09-17 | Ashridge Ag | Balloon catheter |
HU212760B (en) * | 1989-06-20 | 1997-02-28 | Denes | Method and device for the apportion of chemical materials into the vein wall |
EP0574378B1 (en) * | 1989-06-28 | 1995-11-08 | ZIMMON, David S. | Balloon tamponade devices |
US5622188A (en) * | 1989-08-18 | 1997-04-22 | Endovascular Instruments, Inc. | Method of restoring reduced or absent blood flow capacity in an artery |
US5571169A (en) * | 1993-06-07 | 1996-11-05 | Endovascular Instruments, Inc. | Anti-stenotic method and product for occluded and partially occluded arteries |
US6344053B1 (en) * | 1993-12-22 | 2002-02-05 | Medtronic Ave, Inc. | Endovascular support device and method |
US4984564A (en) * | 1989-09-27 | 1991-01-15 | Frank Yuen | Surgical retractor device |
US5108370A (en) * | 1989-10-03 | 1992-04-28 | Paul Walinsky | Perfusion balloon catheter |
US5269785A (en) * | 1990-06-28 | 1993-12-14 | Bonutti Peter M | Apparatus and method for tissue removal |
CA2202800A1 (en) * | 1991-04-11 | 1992-10-12 | Alec A. Piplani | Endovascular graft having bifurcation and apparatus and method for deploying the same |
US6682557B1 (en) * | 1991-04-11 | 2004-01-27 | Endovascular Technologies, Inc. | Bifurcated multicapsule intraluminal grafting system and method |
CA2074304C (en) * | 1991-08-02 | 1996-11-26 | Cyril J. Schweich, Jr. | Drug delivery catheter |
US6503277B2 (en) | 1991-08-12 | 2003-01-07 | Peter M. Bonutti | Method of transplanting human body tissue |
US5306300A (en) * | 1992-09-22 | 1994-04-26 | Berry H Lee | Tubular digestive screen |
US5382231A (en) * | 1993-02-02 | 1995-01-17 | Shlain; Leonard M. | Method for transesophageal retraction of the stomach |
WO1994021196A2 (en) * | 1993-03-18 | 1994-09-29 | C.R. Bard, Inc. | Endovascular stents |
NL9300500A (en) * | 1993-03-22 | 1994-10-17 | Industrial Res Bv | Expandable hollow sleeve for locally supporting and / or strengthening a body vessel, as well as a method for manufacturing it. |
WO1994023669A1 (en) * | 1993-04-13 | 1994-10-27 | Boston Scientific Corporation | Prosthesis delivery system with dilating tip |
WO1994023786A1 (en) * | 1993-04-13 | 1994-10-27 | Boston Scientific Corporation | Prosthesis delivery system |
US5985307A (en) * | 1993-04-14 | 1999-11-16 | Emory University | Device and method for non-occlusive localized drug delivery |
US5433706A (en) * | 1993-10-25 | 1995-07-18 | Cordis Corporation | Perfusion balloon catheter |
US5613948A (en) * | 1993-11-12 | 1997-03-25 | Cordis Corporation | Annular perfusion balloon catheter |
US6245040B1 (en) | 1994-01-14 | 2001-06-12 | Cordis Corporation | Perfusion balloon brace and method of use |
US5484411A (en) * | 1994-01-14 | 1996-01-16 | Cordis Corporation | Spiral shaped perfusion balloon and method of use and manufacture |
US5792300A (en) * | 1994-01-21 | 1998-08-11 | Cordis Corporation | Perfusion catheter and striped extrusion method of manufacture |
US5423851A (en) * | 1994-03-06 | 1995-06-13 | Samuels; Shaun L. W. | Method and apparatus for affixing an endoluminal device to the walls of tubular structures within the body |
US5501667A (en) * | 1994-03-15 | 1996-03-26 | Cordis Corporation | Perfusion balloon and method of use and manufacture |
US6001123A (en) * | 1994-04-01 | 1999-12-14 | Gore Enterprise Holdings Inc. | Folding self-expandable intravascular stent-graft |
US6165210A (en) * | 1994-04-01 | 2000-12-26 | Gore Enterprise Holdings, Inc. | Self-expandable helical intravascular stent and stent-graft |
CA2188563C (en) | 1994-04-29 | 2005-08-02 | Andrew W. Buirge | Stent with collagen |
US6331188B1 (en) | 1994-08-31 | 2001-12-18 | Gore Enterprise Holdings, Inc. | Exterior supported self-expanding stent-graft |
US6015429A (en) * | 1994-09-08 | 2000-01-18 | Gore Enterprise Holdings, Inc. | Procedures for introducing stents and stent-grafts |
US6818014B2 (en) * | 1995-03-01 | 2004-11-16 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
US7204848B1 (en) * | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
DE69622231T2 (en) | 1995-03-01 | 2002-12-05 | Scimed Life Systems Inc | LENGTHFLEXIBLE AND EXPANDABLE STENT |
US6896696B2 (en) | 1998-11-20 | 2005-05-24 | Scimed Life Systems, Inc. | Flexible and expandable stent |
US20070073384A1 (en) * | 1995-03-01 | 2007-03-29 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US6981986B1 (en) | 1995-03-01 | 2006-01-03 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US5707355A (en) * | 1995-11-15 | 1998-01-13 | Zimmon Science Corporation | Apparatus and method for the treatment of esophageal varices and mucosal neoplasms |
JP2000503559A (en) | 1995-12-14 | 2000-03-28 | ゴア エンタープライズ ホールディングス,インコーポレイティド | Apparatus and method for deploying a stent-graft |
US6042605A (en) * | 1995-12-14 | 2000-03-28 | Gore Enterprose Holdings, Inc. | Kink resistant stent-graft |
US6379391B1 (en) | 1999-09-15 | 2002-04-30 | Medidea, Llc | Method and apparatus for positioning a prosthetic element relative to a bone to achieve a desired orientation |
US5743852A (en) * | 1996-04-15 | 1998-04-28 | Johnson; William T. M. | Speculums |
US20040106985A1 (en) * | 1996-04-26 | 2004-06-03 | Jang G. David | Intravascular stent |
JP4636634B2 (en) * | 1996-04-26 | 2011-02-23 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Intravascular stent |
US6241760B1 (en) * | 1996-04-26 | 2001-06-05 | G. David Jang | Intravascular stent |
US6235053B1 (en) * | 1998-02-02 | 2001-05-22 | G. David Jang | Tubular stent consists of chevron-shape expansion struts and contralaterally attached diagonal connectors |
US6152957A (en) * | 1996-04-26 | 2000-11-28 | Jang; G. David | Intravascular stent |
US5733326A (en) * | 1996-05-28 | 1998-03-31 | Cordis Corporation | Composite material endoprosthesis |
US6027528A (en) * | 1996-05-28 | 2000-02-22 | Cordis Corporation | Composite material endoprosthesis |
US5735831A (en) * | 1996-07-10 | 1998-04-07 | Cordis Corporation | Expandable flowrate catheter assembly and method of making same |
US6551350B1 (en) | 1996-12-23 | 2003-04-22 | Gore Enterprise Holdings, Inc. | Kink resistant bifurcated prosthesis |
US6352561B1 (en) | 1996-12-23 | 2002-03-05 | W. L. Gore & Associates | Implant deployment apparatus |
US5925061A (en) * | 1997-01-13 | 1999-07-20 | Gore Enterprise Holdings, Inc. | Low profile vascular stent |
GB9708568D0 (en) * | 1997-04-29 | 1997-06-18 | Smiths Industries Ltd | Cuffed medico-surgical tubes |
US5820584A (en) * | 1997-08-28 | 1998-10-13 | Crabb; Jerry A. | Duodenal insert and method of use |
US6251418B1 (en) * | 1997-12-18 | 2001-06-26 | C.R. Bard, Inc. | Systems and methods for local delivery of an agent |
US6197324B1 (en) | 1997-12-18 | 2001-03-06 | C. R. Bard, Inc. | System and methods for local delivery of an agent |
US6206913B1 (en) * | 1998-08-12 | 2001-03-27 | Vascular Innovations, Inc. | Method and system for attaching a graft to a blood vessel |
US6689121B1 (en) | 1998-09-24 | 2004-02-10 | C. R. Bard, Inc. | Systems and methods for treating ischemia |
US6458092B1 (en) | 1998-09-30 | 2002-10-01 | C. R. Bard, Inc. | Vascular inducing implants |
US6432126B1 (en) | 1998-09-30 | 2002-08-13 | C.R. Bard, Inc. | Flexible vascular inducing implants |
US6248112B1 (en) | 1998-09-30 | 2001-06-19 | C. R. Bard, Inc. | Implant delivery system |
US6692520B1 (en) | 1998-12-15 | 2004-02-17 | C. R. Bard, Inc. | Systems and methods for imbedded intramuscular implants |
US6986784B1 (en) | 1999-05-14 | 2006-01-17 | C. R. Bard, Inc. | Implant anchor systems |
US6855160B1 (en) | 1999-08-04 | 2005-02-15 | C. R. Bard, Inc. | Implant and agent delivery device |
US6689062B1 (en) | 1999-11-23 | 2004-02-10 | Microaccess Medical Systems, Inc. | Method and apparatus for transesophageal cardiovascular procedures |
US6729356B1 (en) | 2000-04-27 | 2004-05-04 | Endovascular Technologies, Inc. | Endovascular graft for providing a seal with vasculature |
AU6299401A (en) * | 2000-05-08 | 2001-11-20 | Qtl Biosystems Llc | Improvements to the fluorescent polymer-qtl approach to biosensing |
US7232421B1 (en) | 2000-05-12 | 2007-06-19 | C. R. Bard, Inc. | Agent delivery systems |
US7204847B1 (en) | 2000-07-28 | 2007-04-17 | C. R. Bard, Inc. | Implant anchor systems |
US20020116049A1 (en) * | 2000-09-22 | 2002-08-22 | Scimed Life Systems, Inc. | Stent |
US7766956B2 (en) * | 2000-09-22 | 2010-08-03 | Boston Scientific Scimed, Inc. | Intravascular stent and assembly |
US8070792B2 (en) | 2000-09-22 | 2011-12-06 | Boston Scientific Scimed, Inc. | Stent |
US7033373B2 (en) | 2000-11-03 | 2006-04-25 | Satiety, Inc. | Method and device for use in minimally invasive placement of space-occupying intragastric devices |
US6558400B2 (en) | 2001-05-30 | 2003-05-06 | Satiety, Inc. | Obesity treatment tools and methods |
US7083629B2 (en) * | 2001-05-30 | 2006-08-01 | Satiety, Inc. | Overtube apparatus for insertion into a body |
US6845776B2 (en) * | 2001-08-27 | 2005-01-25 | Richard S. Stack | Satiation devices and methods |
US20040117031A1 (en) * | 2001-08-27 | 2004-06-17 | Stack Richard S. | Satiation devices and methods |
CN101810521B (en) | 2001-08-27 | 2015-05-13 | 辛尼科有限责任公司 | Satiation devices and methods |
US6675809B2 (en) * | 2001-08-27 | 2004-01-13 | Richard S. Stack | Satiation devices and methods |
US7097665B2 (en) | 2003-01-16 | 2006-08-29 | Synecor, Llc | Positioning tools and methods for implanting medical devices |
US20060292206A1 (en) | 2001-11-26 | 2006-12-28 | Kim Steven W | Devices and methods for treatment of vascular aneurysms |
US7239912B2 (en) | 2002-03-22 | 2007-07-03 | Leptos Biomedical, Inc. | Electric modulation of sympathetic nervous system |
US20030187498A1 (en) * | 2002-03-28 | 2003-10-02 | Medtronic Ave, Inc. | Chamfered stent strut and method of making same |
US7146984B2 (en) * | 2002-04-08 | 2006-12-12 | Synecor, Llc | Method and apparatus for modifying the exit orifice of a satiation pouch |
US6773440B2 (en) * | 2002-07-02 | 2004-08-10 | Satiety, Inc. | Method and device for use in tissue approximation and fixation |
US6746460B2 (en) * | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
US7211114B2 (en) | 2002-08-26 | 2007-05-01 | The Trustees Of Columbia University In The City Of New York | Endoscopic gastric bypass |
US6981978B2 (en) * | 2002-08-30 | 2006-01-03 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
US7033384B2 (en) * | 2002-08-30 | 2006-04-25 | Satiety, Inc. | Stented anchoring of gastric space-occupying devices |
US7214233B2 (en) * | 2002-08-30 | 2007-05-08 | Satiety, Inc. | Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach |
EP1542616B1 (en) | 2002-09-20 | 2015-04-22 | Endologix, Inc. | Stent-graft with positioning anchor |
US7220237B2 (en) * | 2002-10-23 | 2007-05-22 | Satiety, Inc. | Method and device for use in endoscopic organ procedures |
US7229428B2 (en) * | 2002-10-23 | 2007-06-12 | Satiety, Inc. | Method and device for use in endoscopic organ procedures |
US20090149871A9 (en) * | 2002-11-01 | 2009-06-11 | Jonathan Kagan | Devices and methods for treating morbid obesity |
US7794447B2 (en) * | 2002-11-01 | 2010-09-14 | Valentx, Inc. | Gastrointestinal sleeve device and methods for treatment of morbid obesity |
US7837669B2 (en) * | 2002-11-01 | 2010-11-23 | Valentx, Inc. | Devices and methods for endolumenal gastrointestinal bypass |
US20060015125A1 (en) * | 2004-05-07 | 2006-01-19 | Paul Swain | Devices and methods for gastric surgery |
US6656194B1 (en) * | 2002-11-05 | 2003-12-02 | Satiety, Inc. | Magnetic anchoring devices |
US7481821B2 (en) | 2002-11-12 | 2009-01-27 | Thomas J. Fogarty | Embolization device and a method of using the same |
US7695446B2 (en) * | 2002-12-02 | 2010-04-13 | Gi Dynamics, Inc. | Methods of treatment using a bariatric sleeve |
US20070032879A1 (en) * | 2002-12-02 | 2007-02-08 | Levine Andy H | Anti-buckling sleeve |
US7025791B2 (en) * | 2002-12-02 | 2006-04-11 | Gi Dynamics, Inc. | Bariatric sleeve |
EP1569582B1 (en) | 2002-12-02 | 2017-05-31 | GI Dynamics, Inc. | Bariatric sleeve |
US7678068B2 (en) * | 2002-12-02 | 2010-03-16 | Gi Dynamics, Inc. | Atraumatic delivery devices |
US7608114B2 (en) | 2002-12-02 | 2009-10-27 | Gi Dynamics, Inc. | Bariatric sleeve |
US20040143342A1 (en) | 2003-01-16 | 2004-07-22 | Stack Richard S. | Satiation pouches and methods of use |
US20040260382A1 (en) | 2003-02-12 | 2004-12-23 | Fogarty Thomas J. | Intravascular implants and methods of using the same |
US7291160B2 (en) | 2003-03-17 | 2007-11-06 | Delegge Rebecca | Intragastric catheter |
US20040249362A1 (en) * | 2003-03-28 | 2004-12-09 | Gi Dynamics, Inc. | Enzyme sleeve |
GB0307367D0 (en) * | 2003-03-29 | 2003-05-07 | Twg | Composition and method for treating the gastro-intestinal tract |
EP1462116A1 (en) * | 2003-03-29 | 2004-09-29 | Villitech SARL | Composition for treating the gastrointestinal tract |
US7175638B2 (en) | 2003-04-16 | 2007-02-13 | Satiety, Inc. | Method and devices for modifying the function of a body organ |
US6846323B2 (en) | 2003-05-15 | 2005-01-25 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US7731757B2 (en) * | 2003-06-01 | 2010-06-08 | Reflux Corporation | Obesity treatment |
US20050015110A1 (en) * | 2003-07-18 | 2005-01-20 | Fogarty Thomas J. | Embolization device and a method of using the same |
US20060079924A1 (en) * | 2003-07-24 | 2006-04-13 | Femspec Llc | Apparatus for accessing a body cavity and methods of making same |
US7314489B2 (en) * | 2003-08-20 | 2008-01-01 | Ethicon Endo-Surgery, Inc. | Method and apparatus to facilitate nutritional malabsorption |
ATE429192T1 (en) * | 2003-09-24 | 2009-05-15 | Wael Mohamed Nabil Lotfy | LINED BALLOON-MOUNTED STENT |
US20050247320A1 (en) * | 2003-10-10 | 2005-11-10 | Stack Richard S | Devices and methods for retaining a gastro-esophageal implant |
US8206456B2 (en) | 2003-10-10 | 2012-06-26 | Barosense, Inc. | Restrictive and/or obstructive implant system for inducing weight loss |
US7914543B2 (en) | 2003-10-14 | 2011-03-29 | Satiety, Inc. | Single fold device for tissue fixation |
US7097650B2 (en) * | 2003-10-14 | 2006-08-29 | Satiety, Inc. | System for tissue approximation and fixation |
US20050085787A1 (en) * | 2003-10-17 | 2005-04-21 | Laufer Michael D. | Minimally invasive gastrointestinal bypass |
EP1708655A1 (en) * | 2003-12-09 | 2006-10-11 | GI Dynamics, Inc. | Apparatus to be anchored within the gastrointestinal tract and anchoring method |
US8057420B2 (en) * | 2003-12-09 | 2011-11-15 | Gi Dynamics, Inc. | Gastrointestinal implant with drawstring |
US20060212042A1 (en) * | 2005-03-17 | 2006-09-21 | Lamport Ronald B | Removal and repositioning device |
US20050177176A1 (en) * | 2004-02-05 | 2005-08-11 | Craig Gerbi | Single-fold system for tissue approximation and fixation |
EP1713402B1 (en) * | 2004-02-13 | 2018-07-04 | Ethicon Endo-Surgery, Inc. | Device for reducing stomach volume |
US7931693B2 (en) * | 2004-02-26 | 2011-04-26 | Endosphere, Inc. | Method and apparatus for reducing obesity |
US8585771B2 (en) * | 2004-02-26 | 2013-11-19 | Endosphere, Inc. | Methods and devices to curb appetite and/or to reduce food intake |
US8147561B2 (en) * | 2004-02-26 | 2012-04-03 | Endosphere, Inc. | Methods and devices to curb appetite and/or reduce food intake |
EP1725194B1 (en) * | 2004-02-27 | 2018-01-17 | Ethicon Endo-Surgery, Inc. | Methods and devices for reducing stomach volume |
US20050197714A1 (en) * | 2004-03-02 | 2005-09-08 | Sayet Peter H. | System, system devices, and methods for regulating nutrient absorption and caloric intake |
US9028511B2 (en) | 2004-03-09 | 2015-05-12 | Ethicon Endo-Surgery, Inc. | Devices and methods for placement of partitions within a hollow body organ |
US8449560B2 (en) | 2004-03-09 | 2013-05-28 | Satiety, Inc. | Devices and methods for placement of partitions within a hollow body organ |
US8628547B2 (en) | 2004-03-09 | 2014-01-14 | Ethicon Endo-Surgery, Inc. | Devices and methods for placement of partitions within a hollow body organ |
US8252009B2 (en) * | 2004-03-09 | 2012-08-28 | Ethicon Endo-Surgery, Inc. | Devices and methods for placement of partitions within a hollow body organ |
DE102004011764A1 (en) * | 2004-03-09 | 2005-09-29 | Novineon Healthcare Technology Partners Gmbh | Medical implant |
CA2561193A1 (en) | 2004-03-26 | 2005-10-20 | Satiety, Inc. | Systems and methods for treating obesity |
EP1740132B1 (en) | 2004-04-26 | 2014-12-31 | Synecor, LLC | Restrictive and/or obstructive implant for inducing weight loss |
WO2005107641A2 (en) * | 2004-05-03 | 2005-11-17 | Fulfillium, Inc. | Method and system for gastric volume control |
US7803195B2 (en) * | 2004-06-03 | 2010-09-28 | Mayo Foundation For Medical Education And Research | Obesity treatment and device |
US7837643B2 (en) * | 2004-07-09 | 2010-11-23 | Gi Dynamics, Inc. | Methods and devices for placing a gastrointestinal sleeve |
US20060020277A1 (en) * | 2004-07-20 | 2006-01-26 | Gostout Christopher J | Gastric reshaping devices and methods |
EP1778131B1 (en) * | 2004-07-22 | 2012-01-11 | Nellix, Inc. | Systems for endovascular aneurysm treatment |
US8048145B2 (en) | 2004-07-22 | 2011-11-01 | Endologix, Inc. | Graft systems having filling structures supported by scaffolds and methods for their use |
AU2005287010B2 (en) * | 2004-09-17 | 2010-04-15 | Gi Dynamics, Inc. | Gastrointestinal anchor |
US20070078476A1 (en) * | 2004-10-12 | 2007-04-05 | Hull Wendell C Sr | Overweight control apparatuses for insertion into the stomach |
US20060106288A1 (en) | 2004-11-17 | 2006-05-18 | Roth Alex T | Remote tissue retraction device |
US9456915B2 (en) | 2004-11-19 | 2016-10-04 | Fulfilium, Inc. | Methods, devices, and systems for obesity treatment |
US8070807B2 (en) | 2004-11-19 | 2011-12-06 | Fulfillium, Inc. | Wireless breach detection |
US7699863B2 (en) * | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US7785291B2 (en) * | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
US20060222596A1 (en) | 2005-04-01 | 2006-10-05 | Trivascular, Inc. | Non-degradable, low swelling, water soluble radiopaque hydrogel polymer |
JP5070373B2 (en) | 2005-04-28 | 2012-11-14 | エンドーロジックス インコーポレイテッド | Graft system having a filling structure supported by a framework and method of use thereof |
US7976488B2 (en) | 2005-06-08 | 2011-07-12 | Gi Dynamics, Inc. | Gastrointestinal anchor compliance |
EP1903985A4 (en) | 2005-07-07 | 2010-04-28 | Nellix Inc | Systems and methods for endovascular aneurysm treatment |
US9055942B2 (en) * | 2005-10-03 | 2015-06-16 | Boston Scienctific Scimed, Inc. | Endoscopic plication devices and methods |
US20080190989A1 (en) * | 2005-10-03 | 2008-08-14 | Crews Samuel T | Endoscopic plication device and method |
EP1948280A4 (en) * | 2005-10-24 | 2011-07-06 | Andrew Young | Biliary/pancreatic shunt device and method for treatment of metabolic and other diseases |
US10603413B2 (en) * | 2005-11-15 | 2020-03-31 | Allen B. Kantrowitz | Disintegrating digestive tract barrier |
US20070150041A1 (en) * | 2005-12-22 | 2007-06-28 | Nellix, Inc. | Methods and systems for aneurysm treatment using filling structures |
US8376981B2 (en) * | 2006-03-02 | 2013-02-19 | Michael D. Laufer | Gastrointestinal implant and methods for use |
WO2007103773A2 (en) * | 2006-03-02 | 2007-09-13 | Laufer Michael D | Gastrointestinal implant and methods for use |
US20070219618A1 (en) * | 2006-03-17 | 2007-09-20 | Cully Edward H | Endoprosthesis having multiple helically wound flexible framework elements |
US20080228126A1 (en) * | 2006-03-23 | 2008-09-18 | The Trustees Of Columbia University In The City Of New York | Method of inhibiting disruption of the healing process in a physically modified stomach |
US7481836B2 (en) * | 2006-03-30 | 2009-01-27 | Medtronic Vascular, Inc. | Prosthesis with coupling zone and methods |
US7881797B2 (en) * | 2006-04-25 | 2011-02-01 | Valentx, Inc. | Methods and devices for gastrointestinal stimulation |
US7790273B2 (en) * | 2006-05-24 | 2010-09-07 | Nellix, Inc. | Material for creating multi-layered films and methods for making the same |
US9060835B2 (en) * | 2006-05-26 | 2015-06-23 | Endosphere, Inc. | Conformationally-stabilized intraluminal device for medical applications |
US7872068B2 (en) * | 2006-05-30 | 2011-01-18 | Incept Llc | Materials formable in situ within a medical device |
US20080109027A1 (en) * | 2006-08-01 | 2008-05-08 | Fulfillium, Inc. | Method and system for gastric volume control |
US8216297B2 (en) * | 2006-08-14 | 2012-07-10 | Trivascular, Inc. | Dual chamber cuff structure |
US20080065136A1 (en) * | 2006-08-30 | 2008-03-13 | Andrew Young | Distender device and method for treatment of obesity and metabolic and other diseases |
US8109895B2 (en) * | 2006-09-02 | 2012-02-07 | Barosense, Inc. | Intestinal sleeves and associated deployment systems and methods |
US7988720B2 (en) | 2006-09-12 | 2011-08-02 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
US20090125040A1 (en) * | 2006-09-13 | 2009-05-14 | Hambly Pablo R | Tissue acquisition devices and methods |
EP2068719B1 (en) | 2006-09-15 | 2017-10-25 | Boston Scientific Scimed, Inc. | System for anchoring stomach implant |
WO2008039800A2 (en) * | 2006-09-25 | 2008-04-03 | Valentx, Inc. | Toposcopic access and delivery devices |
US8801647B2 (en) * | 2007-02-22 | 2014-08-12 | Gi Dynamics, Inc. | Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks |
WO2008112894A1 (en) * | 2007-03-15 | 2008-09-18 | Jiayi Li | Devices, systems, kits and methods for treatment of obesity |
US9717584B2 (en) * | 2007-04-13 | 2017-08-01 | W. L. Gore & Associates, Inc. | Medical apparatus and method of making the same |
US9642693B2 (en) * | 2007-04-13 | 2017-05-09 | W. L. Gore & Associates, Inc. | Medical apparatus and method of making the same |
US20080255678A1 (en) * | 2007-04-13 | 2008-10-16 | Cully Edward H | Medical apparatus and method of making the same |
JP5331104B2 (en) * | 2007-05-12 | 2013-10-30 | バロセンス、インク | Apparatus and method for gastric segmentation |
US20090012544A1 (en) * | 2007-06-08 | 2009-01-08 | Valen Tx, Inc. | Gastrointestinal bypass sleeve as an adjunct to bariatric surgery |
EP2157919A4 (en) * | 2007-06-11 | 2011-06-22 | Valentx Inc | Endoscopic delivery devices and methods |
US20110137227A1 (en) * | 2007-07-16 | 2011-06-09 | Mckinley James T | Methods and devices for delivering or delaying lipids within a duodenum |
CA2696993C (en) | 2007-07-18 | 2017-01-03 | Samuel T. Crews | Endoscopic implant system and method |
US20090030284A1 (en) * | 2007-07-18 | 2009-01-29 | David Cole | Overtube introducer for use in endoscopic bariatric surgery |
WO2009036244A1 (en) * | 2007-09-12 | 2009-03-19 | Endometabolic Solutions, Inc. | Devices and methods for treatment of obesity |
US20090093839A1 (en) * | 2007-10-04 | 2009-04-09 | Brian Kelleher | Devices and methods for augmenting extragastric banding |
US20090171383A1 (en) | 2007-12-31 | 2009-07-02 | David Cole | Gastric space occupier systems and methods of use |
US7862538B2 (en) * | 2008-02-04 | 2011-01-04 | Incept Llc | Surgical delivery system for medical sealant |
US8020741B2 (en) | 2008-03-18 | 2011-09-20 | Barosense, Inc. | Endoscopic stapling devices and methods |
US20090248059A1 (en) * | 2008-03-25 | 2009-10-01 | Hesham Morsi | Embolectomy Catheter |
US8226593B2 (en) | 2008-04-09 | 2012-07-24 | E2 Llc | Pyloric valve |
US8100850B2 (en) * | 2008-04-09 | 2012-01-24 | E2 Llc | Pyloric valve devices and methods |
US20090259246A1 (en) * | 2008-04-14 | 2009-10-15 | Sherif Eskaros | Intragastric Volume-Occupying Device |
AU2009240419A1 (en) | 2008-04-25 | 2009-10-29 | Nellix, Inc. | Stent graft delivery system |
CA2726596A1 (en) | 2008-06-04 | 2009-12-10 | Nellix, Inc. | Sealing apparatus and methods of use |
AU2009262832A1 (en) * | 2008-06-04 | 2009-12-30 | Nellix, Inc. | Docking apparatus and methods of use |
US8771170B2 (en) * | 2008-08-01 | 2014-07-08 | Microaccess, Inc. | Methods and apparatus for transesophageal microaccess surgery |
US8357118B2 (en) * | 2008-08-26 | 2013-01-22 | Cook Medical Technologies Llc | Balloon catheters having a plurality of needles for the injection of one or more therapeutic agents |
WO2010029190A1 (en) * | 2008-09-15 | 2010-03-18 | Joensson Anders | Medical device, method and system for temporary occlusion of an opening in a lumen of a body |
US7934631B2 (en) | 2008-11-10 | 2011-05-03 | Barosense, Inc. | Multi-fire stapling systems and methods for delivering arrays of staples |
US20100268297A1 (en) * | 2009-02-24 | 2010-10-21 | Hans Neisz | Duodenal Stimulation To Induce Satiety |
US20100228337A1 (en) * | 2009-03-04 | 2010-09-09 | Abbott Laboratories Vascular Enterprises Limited | Mirror image stent and method of use |
US8702641B2 (en) | 2009-04-03 | 2014-04-22 | Metamodix, Inc. | Gastrointestinal prostheses having partial bypass configurations |
US8211186B2 (en) | 2009-04-03 | 2012-07-03 | Metamodix, Inc. | Modular gastrointestinal prostheses |
US9173760B2 (en) | 2009-04-03 | 2015-11-03 | Metamodix, Inc. | Delivery devices and methods for gastrointestinal implants |
US20120065571A1 (en) * | 2009-04-03 | 2012-03-15 | Metamodix, Inc. | Expandable pyloric anchors and methods for securing intestinal bypass sleeves |
US9278019B2 (en) | 2009-04-03 | 2016-03-08 | Metamodix, Inc | Anchors and methods for intestinal bypass sleeves |
US8321030B2 (en) | 2009-04-20 | 2012-11-27 | Advanced Neuromodulation Systems, Inc. | Esophageal activity modulated obesity therapy |
US10772717B2 (en) | 2009-05-01 | 2020-09-15 | Endologix, Inc. | Percutaneous method and device to treat dissections |
WO2010127305A2 (en) | 2009-05-01 | 2010-11-04 | Endologix, Inc. | Percutaneous method and device to treat dissections |
US20100276469A1 (en) * | 2009-05-01 | 2010-11-04 | Barosense, Inc. | Plication tagging device and method |
US8961539B2 (en) | 2009-05-04 | 2015-02-24 | Boston Scientific Scimed, Inc. | Endoscopic implant system and method |
US8340772B2 (en) | 2009-05-08 | 2012-12-25 | Advanced Neuromodulation Systems, Inc. | Brown adipose tissue utilization through neuromodulation |
CN102470038A (en) | 2009-07-10 | 2012-05-23 | 美特默迪克斯公司 | External anchoring configurations for modular gastrointestinal prostheses |
EP2459127B1 (en) | 2009-07-27 | 2015-09-23 | Endologix, Inc. | Stent graft |
WO2011044486A1 (en) * | 2009-10-09 | 2011-04-14 | Boston Scientific Scimed, Inc. | Stomach bypass for the treatment of obesity |
US20110276078A1 (en) | 2009-12-30 | 2011-11-10 | Nellix, Inc. | Filling structure for a graft system and methods of use |
US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US8961501B2 (en) | 2010-09-17 | 2015-02-24 | Incept, Llc | Method for applying flowable hydrogels to a cornea |
WO2012047939A2 (en) * | 2010-10-04 | 2012-04-12 | Ind Platforms Llc | Expandable devices, rail systems, and motorized devices |
US9962275B2 (en) | 2010-10-07 | 2018-05-08 | Randy Louis Werneth | Temporary gastric device (TGD) and method of use |
US9393100B2 (en) | 2010-11-17 | 2016-07-19 | Endologix, Inc. | Devices and methods to treat vascular dissections |
US8963708B2 (en) | 2011-01-13 | 2015-02-24 | Sensurtec, Inc. | Breach detection in solid structures |
US8801768B2 (en) | 2011-01-21 | 2014-08-12 | Endologix, Inc. | Graft systems having semi-permeable filling structures and methods for their use |
US8790388B2 (en) | 2011-03-03 | 2014-07-29 | Boston Scientific Scimed, Inc. | Stent with reduced profile |
EP2680797B1 (en) | 2011-03-03 | 2016-10-26 | Boston Scientific Scimed, Inc. | Low strain high strength stent |
CN103648437B (en) | 2011-04-06 | 2016-05-04 | 恩朵罗杰克斯国际控股有限公司 | For the method and system of vascular aneurysms treatment |
US8636810B2 (en) | 2011-09-28 | 2014-01-28 | Ethicon, Inc. | Negative pressure intestinal anastomosis protection devices |
CA3081285C (en) | 2012-05-14 | 2022-05-31 | C.R. Bard, Inc. | Uniformly expandable stent |
US9358022B2 (en) | 2012-05-21 | 2016-06-07 | Noha, Llc | Clot removal device and method of using same |
CN104334123B (en) | 2012-06-07 | 2019-02-12 | 意比图密医疗有限公司 | Expansion device |
US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
WO2014113483A1 (en) | 2013-01-15 | 2014-07-24 | Metamodix, Inc. | System and method for affecting intestinal microbial flora |
US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
USD723165S1 (en) | 2013-03-12 | 2015-02-24 | C. R. Bard, Inc. | Stent |
WO2014159093A1 (en) | 2013-03-14 | 2014-10-02 | Endologix, Inc. | Method for forming materials in situ within a medical device |
US11129793B2 (en) | 2013-12-05 | 2021-09-28 | Epitomee Medical Ltd | Retentive devices and systems for in-situ release of pharmaceutical active agents |
US20150223956A1 (en) * | 2014-02-12 | 2015-08-13 | Children's National Medical Center | Anchored non-spherical balloon for the treatment of obesity |
US10123896B2 (en) | 2014-03-06 | 2018-11-13 | Mayo Foundation For Medical Education And Research | Apparatus and methods of inducing weight loss using blood flow control |
CN107072652B (en) * | 2014-06-18 | 2019-08-02 | 哈佛学院院长及董事 | Soft retractor |
WO2015200554A1 (en) | 2014-06-26 | 2015-12-30 | Boston Scientific Scimed, Inc. | Medical devices and methods to prevent bile reflux after bariatric procedures |
EP3193780A1 (en) | 2014-09-18 | 2017-07-26 | Boston Scientific Scimed Inc. | Device allowing pyloric sphincter to normally function for bariatric stents |
US10226599B2 (en) * | 2014-12-23 | 2019-03-12 | C.R. Bard, Inc. | Inflatable medical device and related sheath |
WO2017048989A1 (en) * | 2015-09-15 | 2017-03-23 | Fong Kenton D | Devices and methods for anchoring a sheath in a tissue cavity |
US9622897B1 (en) | 2016-03-03 | 2017-04-18 | Metamodix, Inc. | Pyloric anchors and methods for intestinal bypass sleeves |
US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
US10751209B2 (en) | 2016-05-19 | 2020-08-25 | Metamodix, Inc. | Pyloric anchor retrieval tools and methods |
US10588769B2 (en) | 2016-10-12 | 2020-03-17 | Ethicon, Inc. | Caloric bypass device |
US10548753B2 (en) | 2017-01-13 | 2020-02-04 | Ethicon, Inc. | Passive caloric bypass device |
US10765546B2 (en) | 2017-01-25 | 2020-09-08 | Ethicon, Inc. | Modified apparatus for food extraction and obesity treatment |
US10575973B2 (en) | 2018-04-11 | 2020-03-03 | Abbott Cardiovascular Systems Inc. | Intravascular stent having high fatigue performance |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3045677A (en) * | 1960-05-03 | 1962-07-24 | American Cystoscope Makers Inc | Inflatable balloon catheter |
US3046988A (en) * | 1958-12-01 | 1962-07-31 | Davol Rubber Co | Esophageal nasogastric tube |
US3991767A (en) * | 1973-11-02 | 1976-11-16 | Cutter Laboratories, Inc. | Tubular unit with vessel engaging cuff structure |
US4133315A (en) * | 1976-12-27 | 1979-01-09 | Berman Edward J | Method and apparatus for reducing obesity |
US4140126A (en) * | 1977-02-18 | 1979-02-20 | Choudhury M Hasan | Method for performing aneurysm repair |
US4141364A (en) * | 1977-03-18 | 1979-02-27 | Jorge Schultze | Expandable endotracheal or urethral tube |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3834394A (en) * | 1969-11-21 | 1974-09-10 | R Sessions | Occlusion device and method and apparatus for inserting the same |
US3863639A (en) * | 1974-04-04 | 1975-02-04 | Richard N Kleaveland | Disposable visceral retainer |
US4085757A (en) * | 1976-04-29 | 1978-04-25 | P Pevsner | Miniature balloon catheter method and apparatus |
US4134405A (en) * | 1977-01-10 | 1979-01-16 | Smit Julie A | Catheter and intestine tube and method of using the same |
US4246893A (en) * | 1978-07-05 | 1981-01-27 | Daniel Berson | Inflatable gastric device for treating obesity |
US4364392A (en) * | 1980-12-04 | 1982-12-21 | Wisconsin Alumni Research Foundation | Detachable balloon catheter |
US4416267A (en) * | 1981-12-10 | 1983-11-22 | Garren Lloyd R | Method and apparatus for treating obesity |
US4515587A (en) * | 1983-02-14 | 1985-05-07 | Smec, Inc. | IAB having apparatus for assuring proper balloon inflation and deflation |
-
1979
- 1979-05-25 WO PCT/US1979/000354 patent/WO1980000007A1/en unknown
- 1979-06-14 IL IL57559A patent/IL57559A/en unknown
-
1980
- 1980-01-10 EP EP79900673A patent/EP0016047A1/en not_active Withdrawn
- 1980-12-16 US US06/216,989 patent/US4501264A/en not_active Expired - Lifetime
-
1985
- 1985-02-19 US US06/702,828 patent/US4641653A/en not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3046988A (en) * | 1958-12-01 | 1962-07-31 | Davol Rubber Co | Esophageal nasogastric tube |
US3045677A (en) * | 1960-05-03 | 1962-07-24 | American Cystoscope Makers Inc | Inflatable balloon catheter |
US3991767A (en) * | 1973-11-02 | 1976-11-16 | Cutter Laboratories, Inc. | Tubular unit with vessel engaging cuff structure |
US4133315A (en) * | 1976-12-27 | 1979-01-09 | Berman Edward J | Method and apparatus for reducing obesity |
US4140126A (en) * | 1977-02-18 | 1979-02-20 | Choudhury M Hasan | Method for performing aneurysm repair |
US4141364A (en) * | 1977-03-18 | 1979-02-27 | Jorge Schultze | Expandable endotracheal or urethral tube |
Cited By (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2497673A1 (en) * | 1981-01-14 | 1982-07-16 | Harboe Henrik | DEVICE FOR REDUCING THE AVAILABLE VOLUME OF HUMAN STOMACH |
US4416267A (en) * | 1981-12-10 | 1983-11-22 | Garren Lloyd R | Method and apparatus for treating obesity |
US4899747A (en) * | 1981-12-10 | 1990-02-13 | Garren Lloyd R | Method and appartus for treating obesity |
US4485805A (en) * | 1982-08-24 | 1984-12-04 | Gunther Pacific Limited Of Hong Kong | Weight loss device and method |
EP0137878A1 (en) * | 1983-09-06 | 1985-04-24 | Lloyd R. Garren | Stomach insert for treating obesity |
US5401241A (en) * | 1992-05-07 | 1995-03-28 | Inamed Development Co. | Duodenal intubation catheter |
US9060844B2 (en) | 2002-11-01 | 2015-06-23 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US8182459B2 (en) | 2002-11-01 | 2012-05-22 | Valentx, Inc. | Devices and methods for endolumenal gastrointestinal bypass |
WO2004041133A1 (en) * | 2002-11-01 | 2004-05-21 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US9839546B2 (en) | 2002-11-01 | 2017-12-12 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US7037344B2 (en) | 2002-11-01 | 2006-05-02 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
US7220284B2 (en) * | 2002-11-01 | 2007-05-22 | Valentx, Inc. | Gastrointestinal sleeve device and methods for treatment of morbid obesity |
US8968270B2 (en) | 2002-11-01 | 2015-03-03 | Valentx, Inc. | Methods of replacing a gastrointestinal bypass sleeve for therapy adjustment |
US10350101B2 (en) | 2002-11-01 | 2019-07-16 | Valentx, Inc. | Devices and methods for endolumenal gastrointestinal bypass |
US7892214B2 (en) | 2002-11-01 | 2011-02-22 | Valentx, Inc. | Attachment system for transmural attachment at the gastroesophageal junction |
US8012140B1 (en) | 2002-11-01 | 2011-09-06 | Valentx, Inc. | Methods of transmural attachment in the gastrointestinal system |
US9561127B2 (en) | 2002-11-01 | 2017-02-07 | Valentx, Inc. | Apparatus and methods for treatment of morbid obesity |
FR2853829A1 (en) * | 2003-04-16 | 2004-10-22 | Cie Euro Etude Rech Paroscopie | Intra-gastric implant insertion assembly includes sheath with opening edge fastened by releasable locking strip |
WO2004093753A3 (en) * | 2003-04-16 | 2005-01-06 | Cie Euro Etude Rech Paroscopie | Kit for the insertion of an intragastric implant, case for inserting such an implant, and corresponding production method |
WO2004093753A2 (en) * | 2003-04-16 | 2004-11-04 | Compagnie Europeenne D'etude Et De Recherche De Dispositifs Pour L'implantation Par Laparoscopie | Kit for the insertion of an intragastric implant, case for inserting such an implant, and corresponding production method |
EP2164558A4 (en) * | 2007-06-08 | 2010-08-04 | Valentx Inc | Methods and devices for intragastric support of functional or prosthetic gastrointestinal devices |
EP2164558A1 (en) * | 2007-06-08 | 2010-03-24 | Valentx, Inc. | Methods and devices for intragastric support of functional or prosthetic gastrointestinal devices |
US9039649B2 (en) | 2012-05-31 | 2015-05-26 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9451960B2 (en) | 2012-05-31 | 2016-09-27 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9173759B2 (en) | 2012-05-31 | 2015-11-03 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9566181B2 (en) | 2012-05-31 | 2017-02-14 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9675489B2 (en) | 2012-05-31 | 2017-06-13 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9681975B2 (en) | 2012-05-31 | 2017-06-20 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9050168B2 (en) | 2012-05-31 | 2015-06-09 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US8956318B2 (en) | 2012-05-31 | 2015-02-17 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
US9757264B2 (en) | 2013-03-13 | 2017-09-12 | Valentx, Inc. | Devices and methods for gastrointestinal bypass |
Also Published As
Publication number | Publication date |
---|---|
US4641653A (en) | 1987-02-10 |
IL57559A (en) | 1984-06-29 |
US4501264A (en) | 1985-02-26 |
EP0016047A1 (en) | 1980-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4501264A (en) | Medical sleeve | |
US4763653A (en) | Medical sleeve | |
US7033384B2 (en) | Stented anchoring of gastric space-occupying devices | |
US9326879B2 (en) | Systems and methods for bariatric therapy | |
EP2699199B1 (en) | System for bariatric therapy | |
EP1214020B2 (en) | Prosthesis for abdominal aortic aneurysm repair | |
US8114045B2 (en) | Apparatus and methods for delaying gastric emptying to treat obesity | |
US4899747A (en) | Method and appartus for treating obesity | |
US4416267A (en) | Method and apparatus for treating obesity | |
US8870806B2 (en) | Methods of treatment using a bariatric sleeve | |
EP3490465B1 (en) | Stent with one-way sock valve | |
US20090093839A1 (en) | Devices and methods for augmenting extragastric banding | |
EP2760383B1 (en) | Negative pressure intestinal anastomosis protection devices | |
US20070265709A1 (en) | Gastric Bypass Devices and Methods | |
WO2004017863A2 (en) | Endoscopic gastric bypass | |
US20180228632A1 (en) | Devices and Methods for Anchoring an Endoluminal Sleeve in the GI Tract | |
WO2013023676A1 (en) | Devices for anchoring an endoluminal sleeve in the gi tract | |
US20200276040A1 (en) | Applicator and a method for the transpyloric placement or removal of a transpyloric and/or a transduodenal bypass device in/from the region of the pylorus of a patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): BR CH DE DK GB JP SE SU Designated state(s): BR CH DE DK GB JP SE SU |
|
AL | Designated countries for regional patents |
Designated state(s): FR Kind code of ref document: A1 Designated state(s): FR |